Deva Holding A.S. (IST:DEVA)

Market Cap	12.69B
Revenue (ttm)	14.70B
Net Income (ttm)	612.12M
Shares Out	200.02M
EPS (ttm)	3.06
PE Ratio	20.73
Forward PE	n/a
Dividend	0.29 (0.45%)
Ex-Dividend Date	n/a

Volume	427,743
Average Volume	584,435
Open	64.05
Previous Close	64.00
Day's Range	63.20 - 64.05
52-Week Range	51.00 - 81.30
Beta	-0.45
RSI	59.25
Earnings Date	Aug 15, 2025

About Akoya Biosciences

Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, urinary syste...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1958
• Employees: 3,063
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: DEVA

Financial Performance

In 2024, Deva Holding A.S.'s revenue was 15.46 billion, a decrease of -5.50% compared to the previous year's 16.36 billion. Earnings were 69.42 million, a decrease of -98.58%.